Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies
Authors not listed
National Human Genome Research Institute (NHGRI) · 2000
Abstract
The purpose of this study is to learn more about the medical problems and the genetic factors involved in a recently defined form of inherited dementia called "familial dementia with neuroserpin inclusion bodies (FDNIB)." Abnormal substances in nerve cells of patients with this disease affect brain and nervous system function, causing confusion, memory decline and impaired cognition (thinking ability). Patients also develop movement disorders and, possibly, seizures. Symptoms begin in midlife, between 45 and 55 years of age.
Patients with FDNIB and family members 18 years of age or older at risk for the disease may be eligible for this 3-year study.
Participants will have a medical and family history and review of medical records; interview with a medical geneticist (specialist in genetics); physical, neurological and psychiatric examinations; and the following tests and procedures:
1. Blood tests to assess general health
2. Chest and skull X-rays
3. Electrocardiogram (EKG)-record of the electrical activity of the heart using electrodes placed on the chest
4. Electroencephalogram (EEG)-record of the electrical activity of the brain using electrodes placed on the head
5. Ultrasound of the abdomen-imaging of abdominal organs using sound waves
6. Brain magnetic resonance imaging (MRI)-imaging of the brain using a strong magnetic field and radio waves
7. Hearing evaluation
8. Assessment of performance of daily living activities
9. Single photon emission computed tomography (SPECT)-imaging of brain metabolism and blood flow using a radioactive substance injected into a vein
The evaluation will be done over a 3- to 4-day period. At their completion, participants will meet with a physician and a genetics counselor to discuss the clinically significant findings. Participants may be asked to return for follow-up evaluations every 6 months to a year (depending on the individual's condition) for 3 years.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2000). Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies. <em>National Human Genome Research Institute (NHGRI)</em>. https://clinicaltrials.gov/study/NCT00006176
Vancouver
Anonymous. Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies. National Human Genome Research Institute (NHGRI). 2000.
BibTeX
@misc{anon2000Clinic,
title = {Clinical, Molecular and Biochemical Characterization of Familial Encephalopathy With Neuroserpin Inclusion Bodies},
author = {Anonymous},
journal = {National Human Genome Research Institute (NHGRI)},
year = {2000},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Institute of Mental Health (NIMH) 2008
Open access · US-GOV
Measurement of P-Glycoprotein Function in Alzheimer Disease, Parkinson Disease, and Frontotemporal Dementia Using Positron Emission Tomography
National Institute of Neurological Disorders and Stroke (NINDS) 2002
Open access · US-GOV
Dopaminergic Modulation of Cerebral Connectivity During Sequential Finger Movements
Meir Medical Center 2015
Open access · US-GOV
An Evaluation of the Effects of Vitamin D Supplementation on Specific Cognitive Functions and Depressive Symptoms of Older Subjects With Low Levels of This Vitamin
medRxiv 2026
Preprint · CC-BY
A Cerebral Frailty Risk Score Integrating Frailty Index and Neuroimaging for Dementia Prediction in the UK Biobank
biorxiv 2025
Preprint · CC-BY
BIBSNet: A Deep Learning Baby Image Brain Segmentation Network for MRI Scans
Diabetes 2006
Citation only